24Business
Sam Altman-Backed AI Biotech Announces $1 Billion for Its Lofty Goal: Adding 10 Years to Human Life
Retro Biosciences will support clinical trials for three drugs – including a potential Alzheimer’s disease treatment that began studies this year. Read more
Source link
